InvestorsHub Logo
Followers 14
Posts 535
Boards Moderated 0
Alias Born 10/15/2012

Re: Protector post# 105657

Monday, 12/31/2012 9:24:44 PM

Monday, December 31, 2012 9:24:44 PM

Post# of 346514
Update.

Checked the PPHM website today and the pipeline link shows no products in Phase III trials.

This from and article in the WSJ Nov. 16, 2012:

Peregrine's story highlights the role that third-party contractors known as contract research organizations, or CROs, play in drug research. The $25 billion industry--ranging in size from Charles River Laboratories International Inc. (CRL) and closely held Quintiles Inc. to dozens of smaller CROs that perform niche tasks--can handle everything from analyzing data to choosing and conducting oversight of clinical investigators.

Outsourcing those responsibilities has saved drug companies money and quickened the development of life-saving therapies. But the process of supervising CROs has sometimes proven tricky for companies and even the U.S. Food and Drug Administration, as they juggle oversight of dozens of study locations and personnel across the world.

Do companies have a responsibility to supervise these CROs or not?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News